Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Toll like receptors: a new hope on the horizon to treat multiple sclerosis.
Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of abcd1-deficient mice.
Ultrasonographic diagnosis of demyelinating neuropathy.
Reliability of Accelerometer Scores for Measuring Sedentary and Physical Activity Behaviors in Persons With Multiple Sclerosis.
MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis.
Dopaminergic D2-like agonists produce yawning in the myelin mutant taiep and Sprague-Dawley rats.
Alemtuzumab in multiple sclerosis: an update.
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.
Stress, Multiple Sclerosis, and Everyday FunctioningA Review of the Literature with Implications for Intervention.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.
Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes.
[Towards a nursing consultation in neurosexology].
[Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis].
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Multiple sclerosis.
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
[Multiple sclerosis].
Pages
« first
‹ previous
…
449
450
451
452
453
454
455
456
457
…
next ›
last »